Targeted therapy for EGFR-mutated NSCLC, third-generation irreversible EGFR-TKI, active against CNS metastasis, for Ex19Del or L858R mutations, third-line treatment.,
Sale!
Lucius
Replica: Osimertinib EGFRm NSCLC Treatment
Original price was: $688.00.$529.00Current price is: $529.00.
Targeted therapy for EGFR-mutated NSCLC, third-generation irreversible EGFR-TKI, active against CNS metastasis, for Ex19Del or L858R mutations, third-line treatment.,